Recombinant Hemagglutinin HA2 (Diridavumab Biosimilar) antibody
This anti-Hemagglutinin HA2 (Diridavumab Biosimilar) antibody is a Human Monoclonal antibody detecting Hemagglutinin HA2 (Diridavumab Biosimilar) in not_set. Suitable for Influenza A Virus.
Catalog No. ABIN7597628
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant Hemagglutinin HA2 (Diridavumab Biosimilar) antibody (ABIN7597628)
Target
Hemagglutinin HA2 (Diridavumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Influenza A Virus
Host
Human
Clonality
Monoclonal
Conjugate
This Hemagglutinin HA2 (Diridavumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Diridavumab Biosimilar Antibody
-
Specificity
- HA/Hemagglutinin
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1, lambda
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.41 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- Hemagglutinin HA2 (Diridavumab Biosimilar)
-
Alternative Name
- Diridavumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- HA/Hemagglutinin
-
UniProt
- P03455
-
CAS-No
- 1393659-46-5
Target
-
You are here:
